首页> 美国卫生研究院文献>Stem Cells International >Mesenchymal Stromal/Stem Cells in Regenerative Medicine and Tissue Engineering
【2h】

Mesenchymal Stromal/Stem Cells in Regenerative Medicine and Tissue Engineering

机译:间充质基质/干细胞在再生医学和组织工程中的应用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

As a result of over five decades of investigation, mesenchymal stromal/stem cells (MSCs) have emerged as a versatile and frequently utilized cell source in the fields of regenerative medicine and tissue engineering. In this review, we summarize the history of MSC research from the initial discovery of their multipotency to the more recent recognition of their perivascular identity in vivo and their extraordinary capacity for immunomodulation and angiogenic signaling. As well, we discuss long-standing questions regarding their developmental origins and their capacity for differentiation toward a range of cell lineages. We also highlight important considerations and potential risks involved with their isolation, ex vivo expansion, and clinical use. Overall, this review aims to serve as an overview of the breadth of research that has demonstrated the utility of MSCs in a wide range of clinical contexts and continues to unravel the mechanisms by which these cells exert their therapeutic effects.
机译:经过五十多年的研究,间充质基质/干细胞(MSC)已成为再生医学和组织工程领域中一种通用且经常使用的细胞来源。在这篇综述中,我们总结了MSC研究的历史,从它们的多能性的最初发现到其体内血管周身份以及其免疫调节和血管生成信号的非凡能力的最新认识。同样,我们讨论了关于它们的发展起源及其向一系列细胞谱系分化的能力的长期存在的问题。我们还重点介绍了隔离,离体扩增和临床使用方面的重要考虑因素和潜在风险。总体而言,本综述旨在作为研究范围的概述,该研究表明了MSC在广泛的临床环境中的实用性,并继续阐明这些细胞发挥其治疗作用的机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号